• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

硝酸甘油经皮给药治疗慢性稳定性心绞痛的疗效。

Efficacy of transdermal glyceryl trinitrate in the treatment of chronic stable angina pectoris.

作者信息

James M A, Walker P R, Papouchado M, Wilkinson P R

出版信息

Br Heart J. 1985 Jun;53(6):631-5. doi: 10.1136/hrt.53.6.631.

DOI:10.1136/hrt.53.6.631
PMID:3924081
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC481826/
Abstract

A study was carried out to assess the efficacy of a new transdermal preparation of glyceryl trinitrate (Transiderm-Nitro 5) in the 24 hour prophylaxis of angina and to determine the duration of effect of a single patch application. Twelve men with chronic stable angina were studied in a randomised, placebo controlled, double blind trial. By serial treadmill exercise testing a therapeutic effect was shown at three hours; the exercise time to angina and to 1 mm ST segment depression and the total exercise time were all significantly increased. At 24, 48, and 72 hours, however, no therapeutic effect was observed. Recent studies have shown a similar lack of effect at 24 hours for various forms of transdermal delivery systems. It is suggested that this lack of effect is due to the rapid onset of tolerance probably as a result of the constancy of blood concentrations obtained by this method of administration.

摘要

开展了一项研究,以评估新型硝酸甘油透皮制剂(硝酸甘油控释贴片5)在心绞痛24小时预防中的疗效,并确定单次贴片应用的作用持续时间。在一项随机、安慰剂对照、双盲试验中对12名慢性稳定型心绞痛男性患者进行了研究。通过连续跑步机运动试验,在3小时时显示出治疗效果;心绞痛发作时间、ST段压低1毫米的运动时间以及总运动时间均显著增加。然而,在24、48和72小时时,未观察到治疗效果。最近的研究表明,各种形式的透皮给药系统在24小时时也有类似的无效情况。有人认为,这种无效是由于耐受性迅速产生,这可能是由于这种给药方法所获得的血药浓度恒定所致。

相似文献

1
Efficacy of transdermal glyceryl trinitrate in the treatment of chronic stable angina pectoris.硝酸甘油经皮给药治疗慢性稳定性心绞痛的疗效。
Br Heart J. 1985 Jun;53(6):631-5. doi: 10.1136/hrt.53.6.631.
2
Clinical benefit of transdermal glyceryl trinitrate when used with an eight hour patch-free period.使用硝酸甘油透皮贴剂并设置八小时无贴剂期的临床益处。
Aust N Z J Med. 1990 Oct;20(5):677-81. doi: 10.1111/j.1445-5994.1990.tb00398.x.
3
Lack of rebound during intermittent transdermal treatment with glyceryl trinitrate in patients with stable angina on background beta blocker.在使用β受体阻滞剂作为背景治疗的稳定型心绞痛患者中,间歇性经皮给予硝酸甘油期间缺乏反跳现象。
Br Heart J. 1993 Mar;69(3):223-7. doi: 10.1136/hrt.69.3.223.
4
A randomized placebo controlled, double-blind, crossover trial of transdermal nitroglycerin in stable angina pectoris.一项关于经皮硝酸甘油治疗稳定型心绞痛的随机、安慰剂对照、双盲、交叉试验。
Eur Heart J. 1988 Jan;9 Suppl A:73-81. doi: 10.1093/eurheartj/9.suppl_a.73.
5
Avoidance of tolerance and lack of rebound with intermittent dose titrated transdermal glyceryl trinitrate. The Transdermal Nitrate Investigators.间歇性剂量滴定经皮硝酸甘油避免耐受性及无反跳现象。经皮硝酸盐研究人员。
Br Heart J. 1991 Aug;66(2):151-5. doi: 10.1136/hrt.66.2.151.
6
Intermittent transdermal nitroglycerin therapy. Decreased anginal threshold during the nitrate-free interval.间歇性经皮硝酸甘油治疗。无硝酸酯间期心绞痛阈值降低。
Circulation. 1995 Feb 15;91(4):973-8. doi: 10.1161/01.cir.91.4.973.
7
An acute double-blind placebo-controlled study of transdermal glyceryl trinitrate with 12 months' follow-up in patients with stable angina pectoris.一项针对稳定型心绞痛患者的急性双盲安慰剂对照研究,对经皮硝酸甘油进行了为期12个月的随访。
J Int Med Res. 1987 Jul-Aug;15(4):198-204. doi: 10.1177/030006058701500402.
8
Comparison of transdermal nitrate and isosorbide dinitrate in chronic stable angina.慢性稳定型心绞痛中透皮硝酸酯与硝酸异山梨酯的比较。
Br J Clin Pharmacol. 1986 Jul;22(1):15-20. doi: 10.1111/j.1365-2125.1986.tb02873.x.
9
Intermittent transdermal nitroglycerin therapy in angina pectoris. Clinically effective without tolerance or rebound. Minitran Efficacy Study Group.硝酸甘油经皮间歇治疗心绞痛。临床有效,无耐受性或反跳现象。米尼坦疗效研究组。
Circulation. 1995 Mar 1;91(5):1368-74. doi: 10.1161/01.cir.91.5.1368.
10
Determination of the optimal dose of glyceryl trinitrate in the treatment of stable angina.
Eur Heart J. 1987 Jul;8(7):744-7. doi: 10.1093/eurheartj/8.7.744.

引用本文的文献

1
Non-invasive, continuous oral delivery of solid levodopa-carbidopa for management of Parkinson's disease.非侵入式、连续口服给予左旋多巴-卡比多巴固体剂治疗帕金森病。
Sci Rep. 2024 Nov 5;14(1):26826. doi: 10.1038/s41598-024-78145-4.
2
Transdermal glyceryl trinitrate as an effective adjunctive treatment with artemether for late-stage experimental cerebral malaria.经皮硝酸甘油作为青蒿琥酯治疗晚期实验性脑型疟疾的有效辅助治疗方法。
Antimicrob Agents Chemother. 2013 Nov;57(11):5462-71. doi: 10.1128/AAC.00488-13. Epub 2013 Aug 26.
3
Ointments and transdermal nitroglycerin patches for stable angina pectoris.用于稳定型心绞痛的软膏和透皮硝酸甘油贴片。
Cardiovasc Drugs Ther. 1994 Aug;8(4):625-33. doi: 10.1007/BF00877416.
4
Comparison of transdermal nitrate and isosorbide dinitrate in chronic stable angina.慢性稳定型心绞痛中透皮硝酸酯与硝酸异山梨酯的比较。
Br J Clin Pharmacol. 1986 Jul;22(1):15-20. doi: 10.1111/j.1365-2125.1986.tb02873.x.
5
Nitrate tolerance. A review of the evidence.硝酸盐耐受性。证据综述。
Drugs. 1989 Apr;37(4):523-50. doi: 10.2165/00003495-198937040-00006.
6
N-acetylcysteine fails to attenuate haemodynamic tolerance to glyceryl trinitrate in healthy volunteers.在健康志愿者中,N-乙酰半胱氨酸未能减弱对硝酸甘油的血流动力学耐受性。
Br J Clin Pharmacol. 1989 Oct;28(4):421-6. doi: 10.1111/j.1365-2125.1989.tb03522.x.
7
Transdermal nitroglycerin (glyceryl trinitrate). A review of its pharmacology and therapeutic use.经皮硝酸甘油(三硝酸甘油酯)。其药理学与治疗用途综述。
Drugs. 1990 Dec;40(6):880-902. doi: 10.2165/00003495-199040060-00009.
8
Nitrates: why and how should they be used today? Current status of the clinical usefulness of nitroglycerin, isosorbide dinitrate and isosorbide-5-mononitrate.硝酸盐类药物:如今为何以及应如何使用?硝酸甘油、硝酸异山梨酯和5-单硝酸异山梨酯临床应用价值的现状。
Eur J Clin Pharmacol. 1990;38 Suppl 1:S35-51. doi: 10.1007/BF01417564.
9
Transdermal nitroglycerin. Does it really work in the treatment of angina?经皮硝酸甘油。它在心绞痛治疗中真的有效吗?
Drugs Aging. 1991 Jan;1(1):6-16. doi: 10.2165/00002512-199101010-00003.

本文引用的文献

1
THE TWO-PERIOD CHANGE-OVER DESIGN AN ITS USE IN CLINICAL TRIALS.两阶段交叉设计及其在临床试验中的应用。
Biometrics. 1965 Jun;21:467-80.
2
Oral isosorbide dinitrate in the treatment of angina pectoris. Dose-response relationship and duration of action during acute therapy.
Circulation. 1980 Sep;62(3):491-502. doi: 10.1161/01.cir.62.3.491.
3
Determinants of drug response in severe chronic heart failure. 1. Activation of vasoconstrictor forces during vasodilator therapy.重度慢性心力衰竭中药物反应的决定因素。1. 血管扩张剂治疗期间血管收缩力的激活。
Circulation. 1981 Sep;64(3):506-14. doi: 10.1161/01.cir.64.3.506.
4
Human pharmacological studies of a new transdermal system containing nitroglycerin.一种含硝酸甘油的新型透皮给药系统的人体药理学研究。
Eur J Clin Pharmacol. 1982;22(6):473-80. doi: 10.1007/BF00609617.
5
Tolerance to the circulatory effects of oral isosorbide dinitrate. Rate of development and cross-tolerance to glyceryl trinitrate.口服硝酸异山梨酯循环效应的耐受性。硝酸甘油的产生速率及交叉耐受性。
Circulation. 1980 Mar;61(3):526-35. doi: 10.1161/01.cir.61.3.526.
6
Tolerance to isosorbide dinitrate: rate of development and reversal.硝酸异山梨酯耐受性:发展速率与逆转情况
Circulation. 1983 Nov;68(5):1074-80. doi: 10.1161/01.cir.68.5.1074.
7
Comparative evaluation of the effect of two doses of Nitroderm TTS on exercise-related parameters in patients with angina pectoris.两种剂量的硝酸甘油透皮贴剂对心绞痛患者运动相关参数影响的比较评估
Eur Heart J. 1984 Sep;5(9):710-5. doi: 10.1093/oxfordjournals.eurheartj.a061731.
8
Exercise capacity with transdermal nitroglycerin in patients with stable angina pectoris.稳定性心绞痛患者使用经皮硝酸甘油后的运动能力
Eur Heart J. 1984 Sep;5(9):705-9. doi: 10.1093/oxfordjournals.eurheartj.a061730.
9
Transdermal isosorbide dinitrate in angina pectoris: effect of acute and sustained therapy.经皮硝酸异山梨酯治疗心绞痛:急性和持续治疗的效果
Am J Cardiol. 1984 Jul 1;54(1):8-13. doi: 10.1016/0002-9149(84)90296-0.
10
The brief saga of transdermal nitroglycerin discs: paradise lost?透皮硝酸甘油贴剂的简短传奇:失乐园?
Am J Cardiol. 1984 Jul 1;54(1):220-4. doi: 10.1016/0002-9149(84)90333-3.